ODDB.org: Open Drug Database

UCB-Pharma SA - Bimzelx 160 mg, solution injectable en seringue préremplie

Swissmedic Registration	68548	Sequence	01
Product name	Bimzelx 160 mg	Description	solution injectable en seringue préremplie
ATC-Classification	L04AC21	ATC-Description	Bimekizumab
Introduction of Sequence	27.10.2022

Composition

bimekizumabum 160 mg, glycinum, natrii acetas trihydricus, acidum aceticum glaciale, polysorbatum 80, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.45 mg.

Packungsbestandteile

Galenic Form

solution injectable en seringue préremplie

Excipiens

Active Agent	Dose
Bimekizumabum	160 mg/ml

BAG: Active Agent	Dose
Bimekizumabum	160 mg

Inactive agents
Acidum Aceticum Glaciale
Glycin
Natrii Acetas Trihydricus
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		958.13	1058.45	B	SL	No
002	2	1916.26	2100.45	B	SL	No

2025	©ywesee GmbH